Additionally, recent data have suggested that targeting S1PRs in a more specific manner, such as S1PR2 and S1PR4 blockade, displayed an anti-tumoral effect or limited chemotherapy resistance in other tumor indications [102,103,104]. The gene discussed is S1PR2; the disease is neoplasm.